Liquid Biopsy in Advanced Breast Cancer

Meeting Host

Foundation Medicine

Description

When

Wednesday, July 10, 2024
3:30 p.m. ET

Where

A Medical Education Webinare Series

Meeting Details

When a liquid biopsy report identifies a targetable driver, treatment decisions are clear. When there is no driver identified, the next steps are more uncertain. Expert speakers will present their perspectives on liquid biopsy for treatment selection in breast cancer and discuss emerging biomarker ctDNA tumor fraction reported on Foundation Medicine's liquid biopsy test.

Presented by

• Neal Fischbach, MD
  Internationally Recognized Expert in Breast Cancer
• Mia Levy, MD, PhD
  Chief Medical Officer, Foundation Medicine
• Jennifer Mills, PhD
  Moderator
  Vice President, Medical Affairs, Foundation Medicine

Registration

Register Now